These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29205178)

  • 1. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.
    Rotker KL; Alavian M; Nelson B; Baird GL; Miner MM; Sigman M; Hwang K
    Asian J Androl; 2018; 20(2):195-199. PubMed ID: 29205178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.
    Ip FF; di Pierro I; Brown R; Cunningham I; Handelsman DJ; Liu PY
    Eur J Endocrinol; 2010 Feb; 162(2):385-90. PubMed ID: 19903801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets.
    Hayden RP; Bennett NE; Tanrikut C
    J Urol; 2016 Dec; 196(6):1715-1720. PubMed ID: 27287525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement therapy and polycythemia in HIV-infected patients.
    Vorkas CK; Vaamonde CM; Glesby MJ
    AIDS; 2012 Jan; 26(2):243-5. PubMed ID: 22008652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome.
    Moskovic DJ; Freundlich RE; Yazdani P; Lipshultz LI; Khera M
    J Androl; 2012; 33(4):570-3. PubMed ID: 21940986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes with the "V" implantation technique vs. standard technique for testosterone pellet therapy.
    Conners W; Flinn K; Morgentaler A
    J Sex Med; 2011 Dec; 8(12):3465-70. PubMed ID: 21883944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abdominal pain and hypertension in a 55-year-old male patient].
    Kofler T; Yueksel F; Dirnhofer S; Donath MY; Trendelenburg M
    Internist (Berl); 2017 Apr; 58(4):397-401. PubMed ID: 28005140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy.
    Ory J; Nackeeran S; Balaji NC; Hare JM; Ramasamy AR
    J Urol; 2022 Jun; 207(6):1295-1301. PubMed ID: 35050717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism.
    Kaminetsky JC; Moclair B; Hemani M; Sand M
    J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.
    Kovac JR; Rajanahally S; Smith RP; Coward RM; Lamb DJ; Lipshultz LI
    J Sex Med; 2014 Feb; 11(2):553-62. PubMed ID: 24344902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets.
    Pastuszak AW; Mittakanti H; Liu JS; Gomez L; Lipshultz LI; Khera M
    J Androl; 2012; 33(5):927-37. PubMed ID: 22403285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion.
    McCullough AR; Khera M; Goldstein I; Hellstrom WJ; Morgentaler A; Levine LA
    J Sex Med; 2012 Feb; 9(2):594-601. PubMed ID: 22240203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone release rate and duration of action of testosterone pellet implants.
    Kelleher S; Howe C; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):420-8. PubMed ID: 15049955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice.
    Conaglen HM; Paul RG; Yarndley T; Kamp J; Elston MS; Conaglen JV
    J Sex Med; 2014 Feb; 11(2):574-82. PubMed ID: 24279472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy.
    Gosmanov AR; Gemoets DE; Schumacher KA
    J Endocrinol Invest; 2024 Oct; 47(10):2615-2621. PubMed ID: 38536657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment patterns of testosterone replacement medications.
    Donatucci C; Cui Z; Fang Y; Muram D
    J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
    Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism.
    Smith RP; Khanna A; Coward RM; Rajanahally S; Kovac JR; Gonzales MA; Lipshultz LI
    J Sex Med; 2013 Sep; 10(9):2326-33. PubMed ID: 23859250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.